Volume 3, Number 2—June 1997
News and Notes
The First International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms
Highlight and copy the desired format.
|EID||Lal AA, Tibayrenc M. The First International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms. Emerg Infect Dis. 1997;3(2):244-245. https://dx.doi.org/10.3201/eid0302.970226|
|AMA||Lal AA, Tibayrenc M. The First International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms. Emerging Infectious Diseases. 1997;3(2):244-245. doi:10.3201/eid0302.970226.|
|APA||Lal, A. A., & Tibayrenc, M. (1997). The First International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms. Emerging Infectious Diseases, 3(2), 244-245. https://dx.doi.org/10.3201/eid0302.970226.|
Under the auspices of the Centers for Disease Control and Prevention (CDC), ORSTOM (the national French agency for scientific research in developing countries), and CNRS (the national French agency for basic research), the First International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms was held in Atlanta, from June 16 to 19, 1996. The workshop was cosponsored by the National Institutes of Health (NIH), the Burroughs Wellcome Fund, the National Foundation for CDC, Boehringer Mannheim, the French Ministry of Foreign Affairs, and Emory University. Five hundred participants (health care providers, public health professionals, and laboratory scientists) from 25 countries attended the 3-day workshop, whose purpose was to exchange information on the use of molecular tools and approaches in areas of molecular epidemiology and evolutionary genetics in studies of emerging, reemerging, and endemic diseases. The workshop provided an opportunity for CDC, NIH, the World Health Organization, the Walter Reed Army Institute of Research, the Kenya Medical Research Institute, and ORSTOM to present jointly their perspectives on meeting the challenges of emerging infectious disease.
During the workshop, public health and laboratory science-based presentations on parasitic, fungal, bacterial, and viral diseases identified information gaps in the areas of disease and pathogen detection; laboratory-based presentations focused on the use of molecular tools and approaches in pathogen identification and evolution; and other presentations focused on specialized themes, such as the definition of a strain, tools and approaches in molecular epidemiology, emerging infections, concomitant infections, insect disease vectors, opportunistic infections, and tropical parasites.
Many of the challenges of dealing with emerging and reemerging pathogens are common to parasitologists, virologists, bacteriologists, and mycologists. Many pathogens cannot be maintained or propagated in culture or in animal models often because the biology and physiology of these pathogens are not known. This difficulty highlights the advantage of moving directly to molecular probes, polymerase chain reaction amplification, and sequence-based identification for substantiating epidemiologic relationships. Infectious disease clinicians and epidemiologists are faced with whether the disease under investigation is caused by a recently acquired infection or a recrudescent infection and whether an infection is caused by multiple species/strains. In addition, host and pathogen genetic factors that influence susceptibility and pathogenesis and environmental factors that influence transmission of pathogens are critical in the assessment of risk factors for acquiring infections. Molecular approaches to identifying emerging, reemerging, and endemic pathogens were described as most likely to yield the tools needed by epidemiologists to assess the source and risk factors, thus allowing the formulation of needed prevention and control guidelines.
Various approaches and tools now used in detecting pathogens and in studying evolution were examined, and molecular biology and evolutionary genetics applications in the following areas were discussed: 1) diagnosis of known pathogens and development of rapid means to identify unknown pathogens; 2) strain characterization for epidemiologic tracking; 3) ecologic and biologic factors that influence emergence of pathogens; 4) reassessment of taxonomy using molecular biologic data; 5) evaluation of the impact of genetic diversity of microorganisms on vaccine, drug, and insecticide efficacies; 6) gene flow in natural populations of vectors and pathogens; and 7) the role of vectors in the evolution of pathogens. Regardless of the organism under study, a unified approach in evolutionary genetics and population biology was recommended.
Two other topics related to emerging infections were also examined. The first concerned the risk for infection of human recipients of xenogeneic agents through xenotransplantation (and the subsequent transmission of these pathogens to the general population). The second concerned the role of immune activation caused by chronic infections (parasitic and bacterial) and immunization (pneumococcal and influenza) in HIV-infected persons in promoting the replication of HIV and associated progression of disease manifestations. The former is a concern in areas of sub-Saharan Africa and Asia where HIV coexists with parasitic (e.g., malaria and schistosomiasis) and bacterial (e.g., tuberculosis) infections; the latter is a concern in the United States, where pneumococcal and influenza vaccinations are recommended for HIV-infected persons. Field-based, prospective, and longitudinal studies are needed for a complete picture of the extent of interaction between vaccination and pathogen-induced immune activation, HIV replication, and associated rapid progression to AIDS.
The need for a global partnership to facilitate a more rapid identification of infectious agents in a manner that discriminates among closely related strains and species and uses genetic information to study evolution, emergence, and dispersal of infectious agents was emphasized. To address emerging infectious disease threats, CDC has a strategic plan that emphasizes surveillance and applied research for a strong public health-based defense against infectious disease. A goal of this plan is the integration of laboratory science and epidemiology to develop and use tools to detect and promptly identify emerging and reemerging pathogens and investigate factors that influence their emergence. To promote international collaborations and interaction between clinicians, epidemiologists, and laboratory scientists, CDC, ORSTOM, and CNRS will cosponsor the 2nd International Workshop on Molecular Epidemiology and Evolutionary Genetics of Pathogenic Microorganisms at ORSTOM, Montpellier, France from May 26 to 28, 1997.Cite This Article
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 21, 2010
- Page last updated: December 21, 2010
- Page last reviewed: December 21, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)